Cyclin D1 as a Prognostic Factor in Multiple Myeloma and Its Association With the Immunological Prognostic Factor PDL1 and Clinical and Biochemical Lab Tests

NCT05995808 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

PROCEDURE: Bone marow biopsy and aspiration
DIAGNOSTIC_TEST: biochemical and heamatological tests

Sponsor

Sohag University